<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To calculate overall 10-year <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) risk for patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> we applied the UKPDS and SCORE prediction models to data derived from clinical notes of 1846 patients (mean age 65.5 years; 55.8% women) with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> attending eight Primary-Care Centres serving a catchment population of 200,000 citizens in Andalusia </plain></SENT>
<SENT sid="1" pm="."><plain>The results showed <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:mp ids='MP_0002842'>high blood pressure</z:mp> present in &gt;50%, established <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> in 24%, <z:hpo ids='HP_0000488'>retinopathy</z:hpo> in 30%, and <z:hpo ids='HP_0000112'>nephropathy</z:hpo> in 17% </plain></SENT>
<SENT sid="2" pm="."><plain>Mean HbAlc level was 7.3% </plain></SENT>
<SENT sid="3" pm="."><plain>Compliance with therapeutic goals was 54% for systolic blood pressure &lt;130 mmHg, 39% for HbA1c &lt;7% and 9% for <z:chebi fb="1" ids="47774">LDL cholesterol</z:chebi> &lt;2.58 mmol/L </plain></SENT>
<SENT sid="4" pm="."><plain>Approximately 33% were receiving treatment with <z:chebi fb="0" ids="6801">metformin</z:chebi>, <z:chebi fb="0" ids="35664">statins</z:chebi>, renin-angiotensin system inhibitors and anti-aggregation agents </plain></SENT>
<SENT sid="5" pm="."><plain>UKPDS risk for <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> (CHD) was 23% and 16% for <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The SCORE 10-year mortality risk was 5% </plain></SENT>
<SENT sid="7" pm="."><plain>Correlation coefficient between the two models predicting <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk was 0.68 (p&lt;0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>We conclude that, despite the European consensus that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> is low in Mediterranean countries, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> risk factors in the type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> sub-population in southern Spain is relatively high </plain></SENT>
<SENT sid="9" pm="."><plain>Specific measures of health-care intervention are needed if <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>-associated morbido-mortality rates in these diabetic patients are to be reduced </plain></SENT>
</text></document>